ReviewACS omega2026
Emerging Polysaccharide-Based Biomaterials in 3D Bioprinting: Materials, Biomedical Applications, and Future Perspectives.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contemporary healthcare systems require advanced, sustainable, and patient-specific therapeutic solutions. We need advanced technologies, exemplified by 3D printing and biomaterials such as carbohydrates, to produce many 3D-bioprinted in vitro tissues and organ models for drug testing and regenerative medicine. In recent years, polysaccharide-based biomaterials have emerged as promising candidates for three-dimensional (3D) printing applications owing to their intrinsic biocompatibility, biodegradability, tunable physicochemical properties, and structural resemblance to native extracellular matrices (ECMs). In addition, recent progress in biomaterial modification and 3D printing methodologies has broadened their biomedical applications, particularly in tissue engineering, regenerative medicine, organ model development for drug discovery, and in situ bioprinting. This review presents a comprehensive overview of widely utilized polysaccharides in regenerative medicine, 3D printing techniques, bioink formulations, and the biomedical applications of 3D systems. It highlights recent advancements in material design, fabrication strategies, and biological performance and addresses current challenges and future perspectives for translating these materials from laboratory research to clinical practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.